Document is current
Any future updates will be listed below
-
Authors
Xia, Changfa
Xu, Xiaoqian
Zhao, Xuelian
Hu, Shangying
Qiao, Youlin
Zhang, Yong
Hutubessy, Raymond
Basu, Partha
Broutet, Nathalie
Jit, Mark
Zhao, Fanghui
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1216421)
Bill and Melinda Gates Foundation (INV003174)
China Medical Board (16-255)
Peking Union Medical College (2019-1004-02)
- License Information
-
More Information
Article History
Received: 23 September 2020
Accepted: 27 January 2021
First Online: 3 March 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Authors YQ and FZ have received grants through their institution from GlaxoSmithKline Biologicals SA, Merck & Co, Inc., and Xiamen Innovax Biotech Co, Ltd., to undertake clinical trials on the HPV vaccine. Neither YQ nor FZ have received any royalties and do not have intellectual property, patent, or stock holdings with vaccine or drug companies. Other authors declare no competing interests.
